Evolving Cardiac Safety in Drug Discovery: Time for Immunology Integration.

Vicencio, Jose M; Archer, Caroline R; Pointon, Amy

Vicencio, Jose M; Archer, Caroline R; Pointon, Amy.

Afiliação

Vicencio JM; Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge, United Kingdom.
Archer CR; Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge, United Kingdom.
Pointon A; Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge, United Kingdom.

Circulation ; 149(22): 1704-1707, 2024 May 28.

Article em En | MEDLINE | ID: mdl-38805578

Assuntos

Descoberta de Drogas; Humanos; Cardiotoxicidade/etiologia; Animais

Palavras-chave

cardio-oncology; cardiotoxicity; heart failure; immune checkpoint inhibitors; immunotherapy; microphysiological systems; organ-on-chip

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Descoberta de Drogas Limite: Animals / Humans Idioma: En Revista: Circulation Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google